Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04815668Not ApplicableRecruiting

Acupuncture at the Sphenopalatine Ganglion in the Treatment of Moderate-to-severe Seasonal Allergic Rhinitis

Role: collaborator

NCT05551169Completed

Detect and Infer the Severity of COPD by Intelligent Terminal Device

Role: collaborator

NCT04419207Completed

Detecting Lung Cancer Based on Exhaled Breath

Role: collaborator

NCT03083067Not ApplicableCompleted

Salvational Intervention for Reducing AECOPD Under Severe Air Pollution

Role: collaborator

All 4 trials loaded